Publikationen

Publikationen

Consortium of Investigators of Modifiers of (2007) RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

Antoniou, A.C., O.M. Sinilnikova, J. Simard, M. Leone, M. Dumont, S.L. Neuhausen, J.P. Struewing, D. Stoppa-Lyonnet, L. Barjhoux, D.J. Hughes, I. Coupier, M. Belotti, C. Lasset, V. Bonadona, Y.J. Bignon, B.M.C.S. Genetic Modifiers of Cancer Risk in, T.R. Rebbeck, T. Wagner, H.T. Lynch, S.M. Domchek, K.L. Nathanson, J.E. Garber, J. Weitzel, S.A. Narod, G. Tomlinson, O.I. Olopade, A. Godwin, C. Isaacs, A. Jakubowska, J. Lubinski, J. Gronwald, B. Gorski, T. Byrski, T. Huzarski, S. Peock, M. Cook, C. Baynes, A. Murray, M. Rogers, P.A. Daly, H. Dorkins, B. Epidemiological Study of, B.M. Carriers, R.K. Schmutzler, B. Versmold, C. Engel, A. Meindl, N. Arnold, D. Niederacher, H. Deissler, B. German Consortium for Hereditary, C. Ovarian, A.B. Spurdle, X. Chen, N. Waddell, N. Cloonan, C. Kathleen Cuningham Consortium for Research into Familial Breast, T. Kirchhoff, K. Offit, E. Friedman, B. Kaufmann, Y. Laitman, G. Galore, G. Rennert, F. Lejbkowicz, L. Raskin, I.L. Andrulis, E. Ilyushik, H. Ozcelik, P. Devilee, M.P. Vreeswijk, M.H. Greene, S.A. Prindiville, A. Osorio, J. Benitez, M. Zikan, C.I. Szabo, O. Kilpivaara, H. Nevanlinna, U. Hamann, F. Durocher, A. Arason, F.J. Couch, D.F. Easton, G. Chenevix-Trench, and B.. Am J Hum Genet, 81(6): p. 1186-200.

(2007) An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA).

Chenevix-Trench, G., R.L. Milne, A.C. Antoniou, F.J. Couch, D.F. Easton, D.E. Goldgar, and Cimba. Breast Cancer Res, 9(2): p. 104.

Consortium of Investigators of Modifiers of (2007) AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.

Couch, F.J., O. Sinilnikova, R.A. Vierkant, V.S. Pankratz, Z.S. Fredericksen, D. Stoppa-Lyonnet, I. Coupier, D. Hughes, A. Hardouin, P. Berthet, S. Peock, M. Cook, C. Baynes, S. Hodgson, P.J. Morrison, M.E. Porteous, A. Jakubowska, J. Lubinski, J. Gronwald, A.B. Spurdle, kConFab, R. Schmutzler, B. Versmold, C. Engel, A. Meindl, C. Sutter, J. Horst, D. Schaefer, K. Offit, T. Kirchhoff, I.L. Andrulis, E. Ilyushik, G. Glendon, P. Devilee, M.P. Vreeswijk, H.F. Vasen, A. Borg, K. Backenhorn, J.P. Struewing, M.H. Greene, S.L. Neuhausen, T.R. Rebbeck, K. Nathanson, S. Domchek, T. Wagner, J.E. Garber, C. Szabo, M. Zikan, L. Foretova, J.E. Olson, T.A. Sellers, N. Lindor, H. Nevanlinna, J. Tommiska, K. Aittomaki, U. Hamann, M.U. Rashid, D. Torres, J. Simard, F. Durocher, F. Guenard, H.T. Lynch, C. Isaacs, J. Weitzel, O.I. Olopade, S. Narod, M.B. Daly, A.K. Godwin, G. Tomlinson, D.F. Easton, G. Chenevix-Trench, A.C. Antoniou, and B.. Cancer Epidemiol Biomarkers Prev, 16(7): p. 1416-21.

(2007) Genome-wide association study identifies novel breast cancer susceptibility loci.

Easton, D.F., K.A. Pooley, A.M. Dunning, P.D. Pharoah, D. Thompson, D.G. Ballinger, J.P. Struewing, J. Morrison, H. Field, R. Luben, N. Wareham, S. Ahmed, C.S. Healey, R. Bowman, S. collaborators, K.B. Meyer, C.A. Haiman, L.K. Kolonel, B.E. Henderson, L. Le Marchand, P. Brennan, S. Sangrajrang, V. Gaborieau, F. Odefrey, C.Y. Shen, P.E. Wu, H.C. Wang, D. Eccles, D.G. Evans, J. Peto, O. Fletcher, N. Johnson, S. Seal, M.R. Stratton, N. Rahman, G. Chenevix-Trench, S.E. Bojesen, B.G. Nordestgaard, C.K. Axelsson, M. Garcia-Closas, L. Brinton, S. Chanock, J. Lissowska, B. Peplonska, H. Nevanlinna, R. Fagerholm, H. Eerola, D. Kang, K.Y. Yoo, D.Y. Noh, S.H. Ahn, D.J. Hunter, S.E. Hankinson, D.G. Cox, P. Hall, S. Wedren, J. Liu, Y.L. Low, N. Bogdanova, P. Schurmann, T. Dork, R.A. Tollenaar, C.E. Jacobi, P. Devilee, J.G. Klijn, A.J. Sigurdson, M.M. Doody, B.H. Alexander, J. Zhang, A. Cox, I.W. Brock, G. MacPherson, M.W. Reed, F.J. Couch, E.L. Goode, J.E. Olson, H. Meijers-Heijboer, A. van den Ouweland, A. Uitterlinden, F. Rivadeneira, R.L. Milne, G. Ribas, A. Gonzalez-Neira, J. Benitez, J.L. Hopper, M. McCredie, M. Southey, G.G. Giles, C. Schroen, C. Justenhoven, H. Brauch, U. Hamann, Y.D. Ko, A.B. Spurdle, J. Beesley, X. Chen, kConFab, A.M. Group, A. Mannermaa, V.M. Kosma, V. Kataja, J. Hartikainen, N.E. Day, D.R. Cox and B.A. Ponder. Nature, 447(7148): p. 1087-93.

(2007) Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk.

Frank, B., J.L. Bermejo, K. Hemminki, C. Sutter, B. Wappenschmidt, A. Meindl, M. Kiechle-Bahat, P. Bugert, R.K. Schmutzler, C.R. Bartram, and B. Burwinkel. Carcinogenesis, 28(7): p. 1442-5.

(2007) BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study.

Frank, B., K. Hemminki, A. Meindl, B. Wappenschmidt, C. Sutter, M. Kiechle, P. Bugert, R.K. Schmutzler, C.R. Bartram, and B. Burwinkel. BMC Cancer, 7: p. 83.

(2007) Comparison of gene expression data from human and mouse breast cancers: identification of a conserved breast tumor gene set.

Klein, A., R. Wessel, M. Graessmann, M. Jurgens, I. Petersen, R. Schmutzler, D. Niederacher, N. Arnold, A. Meindl, S. Scherneck, S. Seitz, and A. Graessmann. Int J Cancer, 121(3): p. 683-8.

(2007) Association of the BRCA1 missense variant R1699W with a malignant phyllodes tumor of the breast.

Rhiem, K., U. Flucke, C. Engel, B. Wappenschmidt, A. Reinecke-Luthge, R. Buttner, and R.K. Schmutzler. Cancer Genet Cytogenet, 176(1): p. 76-9.

Präventives Versorgungskonzept bei erblichem Brustkrebs, in Prävention und Versorgungsforschung B. Kirch, Pfaff Editor.

Rhiem K, S.R., 2007: Springer Verlag.

(2007) Aurora kinases A and B and familial breast cancer risk.

Tchatchou, S., M. Wirtenberger, K. Hemminki, C. Sutter, A. Meindl, B. Wappenschmidt, M. Kiechle, P. Bugert, R.K. Schmutzler, C.R. Bartram, and B. Burwinkel. Cancer Lett, 247(2): p. 266-72.

(2007) Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk.

Vaclavicek, A., J.L. Bermejo, B. Wappenschmidt, A. Meindl, C. Sutter, R.K. Schmutzler, M. Kiechle, P. Bugert, B. Burwinkel, C.R. Bartram, K. Hemminki, and A. Forsti. Breast Cancer Res Treat, 106(2): p. 205-13.

(2007) Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.

Versmold, B., J. Felsberg, T. Mikeska, D. Ehrentraut, J. Kohler, J.A. Hampl, G. Rohn, D. Niederacher, B. Betz, M. Hellmich, T. Pietsch, R.K. Schmutzler, and A. Waha. Int J Cancer, 121(3): p. 547-54.

(2007) The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer.

Wirtenberger, M., J. Schmutzhard, K. Hemminki, A. Meindl, C. Sutter, R.K. Schmutzler, B. Wappenschmidt, M. Kiechle, N. Arnold, B.H. Weber, D. Niederacher, C.R. Bartram, and B. Burwinkel. Carcinogenesis, 28(2): p. 423-6.